Congress Materials

Medical Information
Ireland
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a healthcare professionalYes, I am a healthcare professional
SelectI am a healthcare professionalYes, I am a healthcare professional
I am a Patient/Caregiver or
Member of the General PublicNo, go back to the patient portal
SelectI am a Patient/Caregiver or
Member of the General PublicNo, go back to the patient portal

If you don't reside in Ireland, please click here

The medical information on this site is intended only for healthcare professionals in the Republic of Ireland. The products discussed herein may have different product labeling in other countries.

This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Oral Presentation
Furlanetto J, Marmé F, Thode C, Nekljudova V, Liu Y, Martin M, Reimer T, Knudsen E, Denkert C, Bassy M, Martin L-A, Karn T, Sinn B, Filipits M, van Mackelenbergh M, Fasching PA, Müller V, Stickeler E, Schem C, Loibl S May 3, 2022 ESMO BC 2022 Breast Cancer

Ovarian Function in Young Patients Treated With Postneoadjuvant Palbociclib and Endocrine Therapy for HR-positive, HER2-negative Early Breast Cancer (BC): Explorative Analysis in Penelope-B

View Presentation
Poster
Rugo HS, Brufsky A, Liu X, Li B, McRoy L, Chen C, Layman RM, Cristofanilli M, Torres MA, Curigliano G, Finn RS, DeMichele A May 4, 2022 ESMO BC 2022 Breast Cancer

Overall Survival With First-line Palbociclib Plus an Aromatase Inhibitor (AI) vs AI in Metastatic Breast Cancer: A Large Real-World Database Analysis

View Presentation View Abstract Plain Language Summary
Poster
Karuturi MS, Blum JL, Anderson D, Kurian S, Wilks S, Wang G, Gauthier E, Zhang Z, Wang Y, Tripathy D, Rocque G May 4, 2022 ESMO BC 2022 Breast Cancer

Palbociclib Treatment in Pre/Perimenopausal Women With Advanced/Metastatic Breast Cancer (ABC/mBC): Real-World Patient Characteristics, Treatment Patterns, and Outcomes Data From POLARIS

View Presentation View Abstract Plain Language Summary